Insider · CIK 0002095805
Yonathan Abraham Nuta
cooofficer
Files at GAIA (GAIA, INC). First filing Dec 8, 2025, latest Mar 6, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$19k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GAIA: GAIA, INC
GAIAOct 9, 2026 · close 1.33
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 64Notable | GAIA, INC | $4,992 1,541 shares | +39% | +5% from low-49% from high | |
| 44Moderate | GAIA, INC | $14k 4,000 shares | - | +10% from low-45% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | GAIA GAIA, INC | POpen-market purchase Class A Common Stock | +1,541 | $3.24 | $4,992 | 5,541 | Mar 6, 2026 |
| Dec 8, 2025 | GAIA GAIA, INC | POpen-market purchase Class A Common Stock | +1,000 | $3.40 | $3,400 | 1,000 | Dec 8, 2025 |
| Dec 8, 2025 | GAIA GAIA, INC | POpen-market purchase Class A Common Stock | +1,000 | $3.45 | $3,450 | 2,000 | Dec 8, 2025 |
| Dec 8, 2025 | GAIA GAIA, INC | POpen-market purchase Class A Common Stock | +2,000 | $3.53 | $7,060 | 4,000 | Dec 8, 2025 |
| Oct 30, 2025 | GAIA GAIA, INC | AGrant or award Restricted Share Unitsderivative | +85,000 | $0.00 | $0 | 85,000 | Nov 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.